According to Compendia, Oncomine Enterprise Edition builds upon the features of Oncomine Professional and Concepts editions by integrating the ability to securely view proprietary gene expression data in comparison with existing public data already available in Oncomine.
Oncomine is a compendium of nearly 26,000 gene expression and DNA copy number profiles collected and curated from the literature and other public sources.
Oncomine Concepts Map, licensed to commercial users as part of the Oncomine Enterprise Edition, uses gene sets as a common language to compare and link disparate biological concepts, allowing researchers to discover and explore new biology based on signatures related to drugs and/or disease pathways.
John Freshley, chief business officer of Compendia, said: “GlaxoSmithKline has long been a leader in the field of cancer genomics and we look forward to working closely with them to advance their oncology discovery and development efforts.”